LOW-DOSE-RATE OR HIGH-DOSE-RATE BRACHYTHERAPY IN COMBINATION WITH EXTERNAL BEAM RADIOTHERAPY FOR INTERMEDIATE AND HIGH-RISK PROSTATE CANCER

ORIGINAL ARTICLES. A. PROTOCOLS OF CLINICAL RESEARCH

https://doi.org/10.37469/0507-3758-2018-64-1-79-83

Published 01.01.2018

Vladimir Solodkiy⁺⁻
Andrey Pavlov⁺⁻
Aleksey Tsybulskiy⁺⁻
Anton Ivashin⁺⁻

Vladimir Solodkiy

Russian Scientific Center of RoentgenoradiologY

Andrey Pavlov

Russian Scientific Center of RoentgenoradiologY

Aleksey Tsybulskiy

Russian Scientific Center of RoentgenoradiologY

Anton Ivashin

Russian Scientific Center of RoentgenoradiologY

##article.numberofdownloads## 35

##article.numberofviews## 128

PDF (Русский)

Keywords

BRACHYTHERAPY
PROSTATE CANCER
COMBINED RADIOTHERAPY

How to Cite

Solodkiy, V., Pavlov, A., Tsybulskiy, A., & Ivashin, A. (2018). LOW-DOSE-RATE OR HIGH-DOSE-RATE BRACHYTHERAPY IN COMBINATION WITH EXTERNAL BEAM RADIOTHERAPY FOR INTERMEDIATE AND HIGH-RISK PROSTATE CANCER. Voprosy Onkologii, 64(1), 79–83. https://doi.org/10.37469/0507-3758-2018-64-1-79-83

Abstract

Introduction. One of the main problems of modem on-courology is treatment for prostate cancer of intermediate and high risk of progression. Modern radiotherapy in this category of patients has an advantage over surgical methods of treatment. One way to improve the effectiveness of radiotherapy is to escalate the dose in the prostate gland. For this purpose a combination of brachytherapy and remote radiotherapy is used. This combination allows increasing the dose of radiation, thereby providing better local control, reducing complications from neighboring organs.

Purpose of the study. To conduct a comparative analysis of efficacy and safety of radical treatment of patients with prostate cancer at medium and high risk of progression using a combination of high and low dose rate brachytherapy with external beam radiotherapy.

Materials and methods. 107 patients with prostate cancer of the group of medium and high risk of progression combined treatment (brachytherapy with external beam radiotherapy) was conducted. 53 patients underwent combined treatment (HDR-brachytherapy and external beam radiotherapy). 54 patients underwent combined treatment (LDR-brachytherapy and external beam radiotherapy). The observation period was 5 years.

Conclusion. In a comparative analysis in groups of combined radiotherapy with the use of high-dose and low-dose-rate brachytherapy, the same effectiveness of immediate and long-term results of treatment was demonstrated. A significant reduction in early and late toxic reactions in patients with high-power brachytherapy has been demonstrated.

https://doi.org/10.37469/0507-3758-2018-64-1-79-83

##article.numberofdownloads## 35

##article.numberofviews## 128

PDF (Русский)

References

Chin J., Rumble B., Kollmeier M. et al. Brachytherapy for Patients With Prostate Cancer: American Society of Clinical Oncology/Cancer Care Ontario Joint Guideline Update // J. Clin. Oncol. - 2017. - Vol. 35.

Grimm P., Billiet I., Bostwick D. et al. Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group // BJU Int. - 2012. - Vol. 109(Suppl. S1). - P. 22-29. - DOI: 10.1111/j.1464-410X.2011.10827.xS

Guedea F., Ventura M., Mazeron J.J. et al. Patterns of care for Brachytherapy in Europe: Facilities and resources in Brachytherapy in the European area // Brachytherapy. - 2008. - Vol. 7. - P. 223-230.

Mottet N., Bellmunt J., Briers E. et. al. European Association of Urology Guidelines on Prostate Cancer, 2015.

NCCN The National Comprehensive Cancer Network, Prostatecancer, 2015.

Peeters S.T.H., Heemsbergen W.D., van Putten W.L.J. et al. Acute and late complications after radiotherapyfor prostate cancer: Results of a multicenter randomized trial comparing 68 Gy to 78 Gy // Int. J. Radiat Oncol. Biol. Phys. - 2005. - Vol. 61. - P. 1019-1034.

Skowronek J. Low-dose-rate or high-dose-rate brachytherapy in treatment of prostate cancer - between options // J. Contemp. Brachytherapy. - 2013. - Vol. 5(1). - P. 33-41.

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Most read articles by the same author(s)

Vladimir Solodkiy, Georgiy Panshin, Aleksey Ivashin, CLINICAL-TOPOMETRIC PREPARATION FOR MODERN CONFORMAL EXTERNAL-BEAM RADIOTHERAPY (PRACTICAL ASPECTS) , Voprosy onkologii : Vol. 63 No. 4 (2017)
Vladimir Solodkiy, Andrey Kaprin, Sergey Ivanov, Dmitriy Fomin, Vladimir Bozhenko, Feliks Sevryukov, Valeriy Krylov, Yekaterina Dzhikiya, Yu. Blanter, Timur Izmaylov, O. Avilov, POSSIBILITIES OF PREOPERATIVE DIAGNOSIS OF IODINE RESISTANCE REGIONAL LYMPH NODES METASTASES OF DIFFERENTIATED THYROID CANCER , Voprosy onkologii : Vol. 65 No. 1 (2019)
Vladimir Solodkiy, Andrey Pavlov, V. Titova, A. Tsybulsky, CONTACT RADIATION THERAPY (BRACHYTHERAPY): CLINICAL CONCEPT OF DIRECT DOSIMETRY [IN VIVO] AND QUALITY ASSURANCE OF RADIATION THERAPY , Voprosy onkologii : Vol. 66 No. 4 (2020)
Vladimir Solodkiy, Georgiy Panshin, Tatyana Shevchenko, Timur Izmailov, The first experience of application of remote radiotherapy in combination with hyperthermia and electrotherapy (oncothermia) in the treatment of patients with primary gliomas of the brain of a high degree of malignancy , Voprosy onkologii : Vol. 67 No. 2 (2021)
Vladimir Solodkiy, Vladimir Sotnikov, Vladimir Kharchenko, Vladimir Chkhikvadze, Georgiy Panshin, Nikolay Nudnov, Aleksandr Morgunov, S. Trotsenko, CHARACTERISTICS OF RELAPSES AFTER SURGICAL AND COMBINED TREATMENT FOR NON-SMALL CELL LUNG CANCER , Voprosy onkologii : Vol. 63 No. 4 (2017)
Nelly Sidibe , Vladimir Solodkiy, Vladimir Sotnikov, Overall survival of patients with nodal non-Hodgkin's lymphomas of the abdominal cavity and pelvis after chemoradiotherapy and chemotherapy. , Voprosy onkologii : Vol. 68 No. 4 (2022)
Vladimir Solodkiy, Andrey Pavlov, Aleksey Tsybulskiy, Aleksandr Pchelintsev, Ivan Moshurov, Nataliya Korotkikh, Dmitriy Kamenev, HIGH-DOSE-RATE AND LOW-DOSE-RATE BRACHYTHERAPY AS MONOTHERAPY FOR CLINICALLY LOCALIZED PROSTATE CANCER , Voprosy onkologii : Vol. 65 No. 3 (2019)
Vladimir Solodkiy, N. Vazhinskaya, Georgiy Panshin, Timur Izmaylov, RESULTS OF COMBINED AND INTEGRATED TREATMENT OF BRAIN STEM TUMORS IN ADULTS , Voprosy onkologii : Vol. 66 No. 2 (2020)
Andrey Pavlov, Vera Titova, Aleksey Tsybulskiy, A. Sumin, Aleksandr Kokontsev, Dmitriy Kokontsev, Andrey Medvedkov, HIGH-DOSE-RATE BRACHYTHERAPY FOR PROSTATE CANCER: DIRECT IN VIVO DOSIMETRY IS AN IMPORTANT FACTOR IN INCREASING THE EFFECTIVENESS OF TREATMENT AND REDUCING THE INCIDENCE OF COMPLICATIONS , Voprosy onkologii : Vol. 65 No. 4 (2019)
Vladimir Solodkiy, Dmitriy Fomin, Olga Khodorovich, Olga Borisova, Olga Lyugay, T. Semakina, Ilya Pyatnitskiy, THE ADVANTAGES OF HYBRID SCINTIGRAPHY IN SENTINEL NODE MAPPING IN PATIENTS WITH BREAST CANCER , Voprosy onkologii : Vol. 65 No. 2 (2019)